Cargando…
Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance
SIMPLE SUMMARY: Recent development of maintenance therapy using PARP inhibitors in ovarian cancer has led to a significant improvement in survival rates. However, resistance to these inhibitors can occur in patients, causing disease progression or relapse. Consequently, novel treatment strategies ar...
Autores principales: | Kyo, Satoru, Kanno, Kosuke, Takakura, Masahiro, Yamashita, Hitomi, Ishikawa, Masako, Ishibashi, Tomoka, Sato, Seiya, Nakayama, Kentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139943/ https://www.ncbi.nlm.nih.gov/pubmed/35626108 http://dx.doi.org/10.3390/cancers14102504 |
Ejemplares similares
-
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study
por: Razia, Sultana, et al.
Publicado: (2023) -
Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation
por: Sato, Seiya, et al.
Publicado: (2023) -
Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022) -
Identifying the Carcinogenic Mechanism of Malignant Struma Ovarii Using Whole-Exome Sequencing and DNA Methylation Analysis
por: Yamashita, Hitomi, et al.
Publicado: (2023) -
Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status
por: Sawada, Kiyoka, et al.
Publicado: (2023)